We observed that inhibition of ACK1 by (R)-9b promoted persistent immune surveillance, impeding tumour growth in syngeneic models of prostate cancer, suggesting that, in addition to T-cell activation, the tumour microenvironment is also involved in tumour growth. This evidence concerns the gene TNK2 and prostate cancer.